FDA Approves Obesity Drug
Developed by Interneuron

The Food and Drug Administration approved an obesity drug made by Interneuron Pharmaceuticals Inc., one of a new class of fat-fighting pills that work on eating impulses in the brain.

Known as Redux, Interneuron's drug has been approved as a prescription therapy to treat obesity. Interneuron says that now that the regulatory hurdles have been cleared, the new fat drug could be available as soon as this summer. Redux will be marketed...